Aug 19, 2011 . Seattle Genetics Inc. won U.S. approval to sell the first new drug for Hodgkin

Aug 24, 2011 . The US Food and Drug Administration (FDA) has granted accelerated approval

Aug 19, 2011 . Cue the Trumpets! Seattle Genetics gained FDA approval to market its antibody

Aug 19, 2011 . Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that the U.S. Food and

Aug 20, 2011 . Thank you for joining us. I am your host Yohemy Auerbach at CRWE Newswire

Oct 11, 2011 . Recently, the FDA granted accelerated approval for Seattle Genetics' ADC drug

Aug 19, 2011 . Adcetris is an antibody-drug that targets a type of lymphoma cell called CD30. It

Aug 19, 2011 . Seattle Genetics' lymphoma drug is approved 10 days earlier than expected.

Aug 19, 2011 . The Food and Drug Administration approved Adcentris, from Seattle Genetics, to

Aug 22, 2011 . Seattle Genetics, Inc. announced that the US Food and Drug Administration (FDA

Aug 20, 2011 . Thank you for joining us. I am your host Yohemy Auerbach at CRWE Newswire

Aug 19, 2011 . First in a new class of ADCs to be FDA-approved- -Seattle Genetics to implement

Oct 13, 2011 . In contrast, Seattle Genetics' Adcetris has had smooth sailing. ODAC voted 10–0

Aug 24, 2011 . On August 19, Seattle Genetics (SGEN) announced that the U.S. Food and Drug

Jul 12, 2011 . This is the week Seattle Genetics, a 14-year-old company, will have its biggest

Seattle Genetics, Inc. is a biotechnology company focused on developing and

Aug 29, 2011 . The FDA gave Seattle Genetics approval to market Adcetris as a treatment for

Aug 22, 2011 . Seattle Genetics, which won early FDA approval for its new lymphoma drug

Aug 22, 2011 . Seattle Genetics noted that the first-in-class treatment, a CD30-directed antibody-

Aug 19, 2011 . Seattle Genetics' big day has arrived, as it has won FDA clearance to start selling

Aug 19, 2011 . WASHINGTON (Reuters) - Drug regulators gave the go ahead on Friday for a blood

Adcetris (brentuximab vedotin) is a new drug in development for the treatment of

Aug 19, 2011 . From Yahoo! News: Federal regulators have approved an innovative cancer drug

Aug 20, 2011 . The Motley Fool - The agency gives a quick turnaround on the new treatment for

Aug 20, 2011 . First in a new class of ADCs to be FDA-approved- -Seattle Genetics to implement

Aug 20, 2011 . Thank you for joining us. I am your host Yohemy Auerbach at CRWE Newswire

Aug 19, 2011 . The FDA on Friday approved Seattle Genetics' Adcetris (brentuximab vedotin) for

Aug 19, 2011 . WASHINGTON (Reuters) - Drug regulators gave the go ahead on Friday for a blood

Aug 20, 2011 . The U.S. Food and Drug Administration today approved Adcetris to treat Hodgkin

Jul 15, 2011 . Also: smoking in youth-rated movies is on the decline; Medicis shares fall after

Aug 22, 2011 . Adcetris is indicated for Hodgkin lymphoma and systemic anaplastic large cell

Aug 19, 2011 . WASHINGTON (Reuters) - Drug regulators gave the go ahead on Friday for a

Aug 19, 2011 . Seattle Genetics ($SGEN) has crossed the finish line. The FDA has granted the

That, at least, is how Seattle Genetics urged investors to think about a tongue

13:58 EDT Seattle Genetics, Takeda receive FDA approval for Adcetris. The FDA

Aug 19, 2011 . FDA approves Seattle Genetics cancer drug, PDF, Print, E-mail . on Friday

Aug 22, 2011 . Seattle Genetics is making news all over the Web today, in the first full business

Aug 19, 2011 . White Plains, NY (August 19, 2011) - Today the Food and Drug Administration (

Aug 22, 2011 . First drug approved for Hodgkins lymphoma since 1977.

First collected on Vodpod.com by karmastock on Aug 20, 2011.

Aug 19, 2011 . Seattle Genetics Announces FDA Accelerated Approval of ADCETRIS™. (

Aug 19, 2011 . WASHINGTON (dpa-AFX) - Seattle Genetics Inc. (SGEN) Friday announced that

Aug 19, 2011 . SILVER SPRING, Md., Aug. 19, 2011 /PRNewswire-USNewswire/ -- The U.S.

Aug 19, 2011 . A new drug from Seattle Genetics was approved by the Food and Drug

Aug 19, 2011 . WASHINGTON (AP) — Federal regulators have approved an innovative cancer drug

Nov 4, 2011 . A confirmatory trial design of Adcetris plus AVD versus ABVD is obviously not a

Aug 19, 2011 . Federal regulators have approved an innovative cancer drug from Seattle

Aug 19, 2011 . The U.S. Food and Drug Administration has approved Bothell-based Seattle

Jul 15, 2011 . An experimental drug from Seattle Genetics Inc garnered unanimous backing

Aug 19, 2011 . Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that the U.S. Food and

Sitemap